Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease.

Hematology (Amsterdam, Netherlands) - 1 Jun 2015

Ataga Kenneth I, Hinderliter Alan, Brittain Julia E, Jones Susan, Xu Hao, Cai Jianwen, Kim Soyoung, Pritchard Kirkwood A, Hillery Cheryl A

Abstract excerpt

Background Although cholesterol levels are known to be decreased in sickle cell disease (SCD), the level of pro-inflammatory high-density lipoprotein cholesterol (proHDL) and its association with clinical complications and laboratory variables has not been evaluated. Design and methods Plasma levels of total cholesterol, high-density lipoprotein cholesterol (HDL), proHDL, and selected clinical and laboratory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to Blood Coagulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, HDL

Share to Erythrocyte Indices

Share to Hemoglobins

Share to Hemolysis

Share to Inflammation

Share to Lipids

Source

Open in PubMed Open full text

Identifiers

PMID: 24801127
DOI: 10.1179/1607845414Y.0000000171
PMCID: PMC4223013

Genes

SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease.PMID 24801127Read ↗

CETP gene polymorphisms and haplotypes are explanatory variables for HDL cholesterol level in sickle cell disease.Semantic proximity Read ↗

Clinical biomarkers in sickle cell diseaseSemantic proximity Read ↗

Subclinical Organ Dysfunction and Early Mortality Risk in Sickle Cell Disease: Integrating Biomarkers and Precision Medicine ApproachesSemantic proximity Read ↗

Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients, as a function of therapeutic transfusion and hydroxyurea treatmentSemantic proximity Read ↗

Transforming Growth Factor Beta Receptor 3 Haplotypes in Sickle Cell Disease Are Associated with Lipid Profile and Clinical Manifestations.Semantic proximity Read ↗

Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology.Semantic proximity Read ↗

Association of Normal and Mutated APOL1 G2 Rs60910145 alleles with SCD, Body Mass Index, and Renal Function Biomarkers and Indices.Semantic proximity Read ↗

Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe.Semantic proximity Read ↗

Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases.Semantic proximity Read ↗

Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.Semantic proximity Read ↗

Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease.Semantic proximity Read ↗

Association between apolipoprotein ε4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in Southern Iran.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.